KIMBERLY AGENT: Open Payments
NPI 1871805820 · CARTHAGE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 30 payments from 11 companies in 2025. Trend: 2023 $675 · 2024 $670 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Verona Pharma, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| Averitas Pharma Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| Abbott Laboratories | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: FARXIGA, BREZTRI, Ohtuvayre, Ozempic, QUTENZA, LINZESS, VOQUEZNA, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
